CPIX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cumberland Pharmaceuticals Inc (CPIX) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available. The technical indicators are neutral, options data shows limited trading sentiment, and the financial performance is mixed with revenue growth but declining net income and EPS. There are no significant positive catalysts or recent news to drive the stock upward. Holding or exploring other opportunities may be more suitable.
The MACD is positive but contracting, RSI is neutral at 47.409, and moving averages are converging, indicating no clear trend. Support is at $3.00, and resistance is at $3.715. The stock is trading below the pivot level of $3.357, suggesting weakness.
Revenue increased by 31.08% YoY in Q4 2025, and gross margin improved to 76.21%, up 13.63% YoY.
No recent news, no significant insider or hedge fund activity, and no recent congress trading data. Stock trend analysis suggests a likelihood of small negative returns in the short term.
In Q4 2025, revenue grew by 31.08% YoY to $13,678,651, but net income declined by 25.85% YoY to -$1,411,692, and EPS fell by 28.57% YoY to -$0.1. Gross margin improved to 76.21%, up 13.63% YoY.
No analyst rating or price target data available for CPIX.
